SAN FRANCISCO, CA--(Marketwire - October 16, 2007) - Linkage Biosciences Inc., a developer of molecular diagnostics products designed to streamline complex genetic testing, has completed a financing round led by Greenhouse Capital Partners LP, a seed-stage venture capital firm, which brings the total funding raised thus far to approximately $1 million. Linkage Biosciences said the new funds will be used to accelerate development of its initial line of diagnostic products for solid organ and stem cell transplantation.
